A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.
Tomizawa Y, Ishihara S, Iijima H, Imai H, Sato K, Yatomi M, Iwasaki Y, Yamada H, Kobayashi G, Ishida E, Inoue T, Aoki H, Watanabe S, Kawashima O, Mori M, Saito R.
Tomizawa Y, et al. Among authors: imai h.
Am J Clin Oncol. 2007 Oct;30(5):498-502. doi: 10.1097/01.coc.0000264179.23080.bc.
Am J Clin Oncol. 2007.
PMID: 17921710
Clinical Trial.